Ardelyx (ARDX) EBT Margin (2013 - 2026)

Ardelyx (ARDX) posted EBT Margin of 39.8% for Q1 2026, down 12357.81% on a QoQ basis from 0.32% in Q4 2025, and up 1456.0% year-over-year from 2.56% in Q1 2025.

Ardelyx (ARDX) EBT Margin (2013 - 2026) Analysis & Trends

Ardelyx's EBT Margin history runs 12 years deep, the most recent figure standing at 39.8% for Q1 2026.

  • Quarterly EBT Margin rose 1456.0% year-over-year to 39.8% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 18.06% (down 348.0% YoY) and the FY2025 annual result came in at 14.89%, down 323.0% from the prior year.
  • EBT Margin was 39.8% for Q1 2026 at Ardelyx, down from 0.32% in the prior quarter.
  • Across five years, EBT Margin topped out at 24.21% in Q4 2022 and bottomed at 5997.65% in Q1 2022.
  • A 5-year average of 476.33% and a median of 39.8% in 2026 frame the typical range for EBT Margin.
  • Annual changes were most pronounced in 2022 — EBT Margin slumped 549394 bps — and 2023, when it soared 576228 bps.
  • Ardelyx's EBT Margin stood at 24.21% in 2022, then tumbled by 442 bps to 82.85% in 2023, then surged by 105 bps to 4.03% in 2024, then sank by 108 bps to 0.32% in 2025, then sank by 12358 bps to 39.8% in 2026.
  • Business Quant data shows ARDX's EBT Margin at 39.8% in Q1 2026, 0.32% in Q4 2025, and 25.5% in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 17.13%
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 41.95%
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 23.05%
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 34.77%
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Ardelyx 1.26 Bn 1.02 Bn 89.66 Mn -39.80%

Historic Data

Download Data
DateValue
Mar 31, 2026 -39.80%
Dec 31, 2025 -0.32%
Sep 30, 2025 -25.50%
Jun 30, 2025 -19.53%
Mar 31, 2025 -54.36%
Dec 31, 2024 4.03%
Sep 30, 2024 -0.78%
Jun 30, 2024 -22.38%
Mar 31, 2024 -57.36%
Dec 31, 2023 -82.85%
Sep 30, 2023 12.11%
Jun 30, 2023 -76.66%
Mar 31, 2023 -235.37%
Dec 31, 2022 24.21%
Sep 30, 2022 -459.15%
Jun 30, 2022 -1,066.19%
Mar 31, 2022 -5,997.65%
Dec 31, 2021 -3,521.28%
Sep 30, 2021 -3,715.77%
Jun 30, 2021 -3,441.51%